trial · primary record
PG4
Pneumococcal Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 2400 |
| Primary completion | 2028-12-30 |
| Primary endpoint | Percentage of participants reporting local reactions within 7 days after each dose |
| Registry ID | NCT07573462 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:07.623Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07573462
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.